A Review of metabolic staging in severely injured patients

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

Volumn 18, Issue 1, 2010, Pages

  Aller, Maria Angeles ^a   Arias, Jose Ignacio ^b   Alonso Poza, Alfredo ^c   Arias, Jaime ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Monte Naranco Hospital   (Spain)

^c Arganda del Rey   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; INJURY; INJURY SCALE; METABOLISM; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

HUMANS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRAUMA SEVERITY INDICES; WOUNDS AND INJURIES;

EID: 79955912676     PISSN: None     EISSN: 17577241     Source Type: Journal    
DOI: 10.1186/1757-7241-18-27     Document Type: Review

References (105)

1. Vodovotz Y, Csete M, Bartels J, Chang S, An G. Translocational systems biology of inflammation. PLOS Comput Biol 2008, 4:1-6.
2. Kohl BA, Deutschman CS. The inflammatory response to surgery and trauma. Curr Opin Crit Care 2006, 12:325-332. 10.1097/01.ccx.0000235210.85073.fc, 16810043.
3. Choileain NN, Redmond HP. Cell response to surgery. Arch Surg 2006, 141:1132-1140. 10.1001/archsurg.141.11.1132, 17116807.
4. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury 2007, 38:1336-1345. 10.1016/j.injury.2007.10.003, 18048040.
5. Gebhard F, Huber-Lang M. Polytrauma-phatophysiology and management principles. Langenbecks Arch Surg 2008, 393:825-831. 10.1007/s00423-008-0334-2, 18431593.
6. Cuthbertson DP. The metabolic response to injury and other related explorations in the field of protein metabolism: An autobiographic account. Scot Med J 1982, 27:158-171.
7. Selye H. The part of inflammation in the local adaptation syndrome. Rev Can Biol 1953, 12:155-175.
8. Moore FD. Bodily changes in surgical convalescence. I - The normal sequence-Observations and interpretations. Ann Surg 1953, 137:289-315. 10.1097/00000658-195303000-00001, 1802509, 13031458.
9. Zerhouni E. The NIH roadmap. Science 2003, 302:63-72. 10.1126/science.1091867, 14526066.
10. Gittes GK. The surgeon-scientist in a new biomedical research era. Surgery 2006, 140:123-131. 10.1016/j.surg.2006.06.008, 16904961.
11. Aller MA, Arias JL, Lorente L, Nava MP, Durán HJ, Arias J. Neuro-immune-endocrine functional system and vascular pathology. Med Hypotheses 2001, 57:561-569. 10.1054/mehy.2001.1408, 11735311.
12. Aller MA, Arias JL, Nava MP, Arias J. Post-traumatic inflammation is a complex response based on the pathological expression of the nervous, immune, and endocrine functional systems. Exp Biol Med (Maywood) 2004, 229:170-181.
13. Aller MA, Arias JL, Sánchez-Patán F, Arias J. The inflammatory response: An efficient way of life. Med Sci Monit 2006, 12:RA225-234.
14. Aller MA, Arias JL, Cruz A, Arias J. Inflammation: a way to understanding the evolution of portal hypertension. Theor Biol Med Model 2007, 4:44. 10.1186/1742-4682-4-44, 2206015, 17999758.
15. Eisenhut M. Changes in ion transport in inflammatory disease. J Inflamm 2006, 3:5.
16. Häussinger D. The role of cellular hydration in the regulation of cell function. Biochem J 1996, 313:697-710. 1216967, 8611144.
17. O'Connor TM, O'Halloran DJ, Shanahan F. The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia. QJM 2000, 93:323-333. 10.1093/qjmed/93.6.323, 10873181.
18. Cuthbetson DP. Alterations in metabolism following injury: Part I. Injury 1980, 11:175-189. 10.1016/S0020-1383(80)80041-6, 6988332.
19. Hill AG, Hill GL. Metabolic response to severe injury. Br J Surg 1998, 85:884-890. 10.1046/j.1365-2168.1998.00779.x, 9692557.
20. Singer M, De Santis V, Vitale D, Jeffcoate W. Multiorgan failure is an adaptative, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004, 364:545-548. 10.1016/S0140-6736(04)16815-3, 15302200.
21. Schaller B, Graf R. Hypothermia and stroke: the pathophysiological background. Pathophysiology 2003, 10:7-35. 10.1016/j.pathophys.2003.09.001, 14643901.
22. Selye H. Stress and the general adaptation syndrome. Br Med J 1950, 1:1383-1392. 10.1136/bmj.1.4667.1383, 2038162, 15426759.
23. Cuthbertson DP. Alterations in metabolism following injury: part II. Injury 1980, 11:286-303. 10.1016/0020-1383(80)90101-1, 6997201.
24. Douglas RG, Shaw JH. Metabolic response to sepsis and trauma. Br J Surg 1989, 78:115-122.
25. Cuthbertson DP. The distribution of nitrogen and sulphur in the urine during conditions of increased catabolism. Biochem J 1931, 25:236-244. 1260632, 16744572.
26. Lloyd D. Hydrogen sulfide: clandestine microbial messenger?. Trends Microb 2006, 14:456-462.
27. Kwak WJ, Kwon GS, Jin I, Kuriyama H, Sohn HY. Involvement of oxidative stress in the regulation of H2S production during circadian metabolic oscillation of Saccharomyces cerevisae. FEMS Microbiol Lett 2003, 219:99-104. 10.1016/S0378-1097(02)01198-9, 12594030.
28. Lowicka E, Bettowski J. Hydrogen sulfide (H2S)- the third gas of interest for pharmacologists. Pharmacol Rep 2007, 59:4-24.
29. Blackstone E, Morrison M, Roth MB. H2S induces a suspended animation-like state in mice. Science 2005, 308:518. 10.1126/science.1108581, 15845845.
30. Blackstone E, Roth MB. Suspended animation-like state protects mice from lethal hypoxia. Shock 2007, 27:370-372. 10.1097/SHK.0b013e31802e27a0, 17414418.
31. Weisfeldt ML, Becker LB. Resuscitation after cardiac arrest: A 3-phase time-sensitive model. JAMA 2002, 288:3035-3038. 10.1001/jama.288.23.3035, 12479769.
32. Ali BA, Zafari AM. Cardiopulmonary resuscitation and emergency cardiovascular care: Review of the current guidelines. Ann Intern Med 2007, 147:171-179.
33. Krausz MM. Initial resuscitation of hemorrhagic shock. World J Emergency Surg 2006, 1:14.
34. Velmahos GC, Alam HB. Advances in surgical critical care. Curr Probl Surg 2008, 45:453-516. 10.1067/j.cpsurg.2008.03.003, 18503823.
35. Rushing GD, Britt LD. Reperfusion injury after hemorrhage. A collective review. Ann Surg 2008, 247:929-937. 10.1097/SLA.0b013e31816757f7, 18520219.
36. Flores HA, Stewart RM. The multiply injured patient. Semin Thorac Cardiovasc Surg 2008, 20:64-68. 10.1053/j.semtcvs.2008.01.007, 18420129.
37. Rotondo MF, Schwab CW, McGonigal MD. Damage control: an approach for improved survival in exanguinating penetrating abdominal injury. J Trauma 1993, 35:375-383. 10.1097/00005373-199309000-00008, 8371295.
38. Stahel PF, Smith WR, Moore EE. Role of biological modifiers regulating the immune response after trauma. Injury 2007, 38:1409-1422. 10.1016/j.injury.2007.09.023, 18048034.
39. Germanos S, Gourgiotis S, Villias C, Bertucci M, Dimopoulos N, Salemis N. Damage control surgery in the abdomen: An approach for the management of severe injured patients. Intern J Surg 2008, 6:246-252.
40. Gentilello LM, Pierson DJ. Trauma critical care. Am J Respir Crit Care Med 2001, 163:604-607.
41. Lausevic Z, Lausevic M, Trbojevic-Stankovic J, Krstic S, Stojimirovic B. Predicting multiple organ failure in patients with severe trauma. Can J Surg 2000, 51:97-102.
42. Moore FA, Sauaia A, Moore EE, Norris JM, Lezotte DC, Hamman RF. Postinjury multiple organ failure. A bimodal phenomenon. J Trauma 1996, 40:501-512. 10.1097/00005373-199604000-00001, 8614027.
43. Legrand M, Mik EG, Johannes T, Payen D, Ince C. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med 2008, 14:502-516. 10.2119/2008-00006.Legrand, 2386087, 18488066.
44. Haddad JJ. Oxygen sensing and oxidant/redox-related pathways. Biochem Biophys Res Comm 2004, 316:969-977. 10.1016/j.bbrc.2004.02.162, 15044079.
45. Lopez-Lazaro M. HIF-1: hypoxia-inducible factor or dysoxia-inducible factor?. FASEB J 2006, 20:828-832. 10.1096/fj.05-5168hyp, 16675839.
46. Michiels C. Physiological and pathological responses to hypoxia. Am J Pathol 2004, 164:1875-1882. 1615763, 15161623.
47. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U, Bondesson M. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Develop Cell 2005, 9:617-628.
48. Bach FH. Carbon monoxide: from the origin of life to molecular medicine. TRENDS Mol Med 2006, 12:348-350. 10.1016/j.molmed.2006.06.007, 16829200.
49. Iwase H, Robin E, Guzy RD, Mungai PT, Hoek TL, Chandel NS, Levraut J, Schumacker PT. Nitric oxide during ischemia attenuates oxidant stress and cell death during ischemia and reperfusion in cardiomyocytes. Free Rad Biol Med 2007, 43:590-599. 10.1016/j.freeradbiomed.2007.05.017, 17640569.
50. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005, 9:S13-S19. 10.1186/cc3753, 16168069.
51. Fisher EM, Lamanna JC. Gut dysoxia: comparison of sites to detect regional gut dysoxia. Adv Exp Med Biol 2000, 566:151-157.
52. Foëx A. Systemic response to trauma. Br Med Bull 1999, 55:726-743. 10.1258/0007142991902745, 10746327.
53. Garrison RN, Spain DA, Wilson MA, Keelen PA, Harris PD. Microvascular changes explain the "two-hit" theory of multiple organ failure. Ann Surg 1998, 227:851-860. 10.1097/00000658-199806000-00008, 1191390, 9637548.
54. Meldrum DR, Cleveland JC, Moore EE, Partrick DA, Banerjee A, Harken AH. Adaptative and maladaptative mechanisms of cellular priming. Ann Surg 1997, 226:587-598. 10.1097/00000658-199711000-00003, 1191120, 9389392.
55. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV. Multiple-Organ-Failure Syndrome. Arch Surg 1986, 121:196-208.
56. Stoner HB. Interpretation of the metabolic effects of trauma and sepsis. J Clin Pathol 1987, 40:1108-1117. 10.1136/jcp.40.9.1108, 1141178, 3312301.
57. Atiyeh BS, Gunn WA, Dibo SA. Metabolic implications of severe burn injuries and their management: A systematic review of the literature. World J Surg 2008, 32:1857-1869. 10.1007/s00268-008-9587-8, 18454355.
58. Jeschke MG, Chinkes DL, Finnerty CC, Kulp G, Suman OE, Norbury WB, Branski LK, Gauglitz GG, Mlcak RP, Herndon DN. Pathophysiologic response to severe burn injury. Ann Surg 2008, 248:387-401. 10.1097/SLA.0b013e318176c4b3, 18791359.
59. Keel M, Trentz O. Pathophysiology of polytrauma. Injury 2005, 36:691-709. 10.1016/j.injury.2004.12.037, 15910820.
60. Vanhorebeek I, Langouche L, Berghe G. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2006, 2:20-31. 10.1038/ncpendmet0071, 16932250.
61. Moore FA, Moore EE. Evolving concepts in the pathogenesis of post-injury multiple organ failure. Surg Clin North Am 1995, 75:257-277.
62. Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, Caldwell C, Ohta A, Thiel M. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2 receptors. Ann Rev Immunol 2004, 22:21.1-21.26.
63. Splettstoesser WD, Schuff-Werner P. Oxidative stress in phagocytes. "The enemy within". Microsc Res Tech 2002, 57:441-455. 10.1002/jemt.10098, 12112427.
64. Brunengraber H, Roe CR. Anaplerotic molecules: Current and future. J Inherit Metab Dis 2006, 29:327-331. 10.1007/s10545-006-0320-1, 16763895.
65. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008, 7:11-20. 10.1016/j.cmet.2007.10.002, 18177721.
66. Griffiths RD, Hinds CJ, Little RA. Manipulating the metabolic response to injury. Br Med Bull 1999, 55:181-195. 10.1258/0007142991902204, 10695086.
67. Hanada T, Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Fact Rev 2002, 13:413-421.
68. Smith EM. Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis. Brain Behav Immun 2007, 22:3-14. 10.1016/j.bbi.2007.08.005, 2194290, 17900859.
69. Stephanou A, Jessop DS, Knight RA, Lightman SL. Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain Behav Immun 1990, 4:67-73. 10.1016/0889-1591(90)90007-D, 2334816.
70. Flierl MA, Rittirsch D, Huber-Lang M, Sarma JV, Ward PA. Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening Pandora's box?. Mol Med 2008, 14:195-204. 2136428, 18079995.
71. Czura CJ, Tracey KJ. Autonomic neural regulation of immunity. J Intern Med 2005, 257:156-166. 10.1111/j.1365-2796.2004.01442.x, 15656874.
72. Menger MD, Vollmar B. Surgical trauma: hyperinflammation versus immunosuppression?. Langenbecks Arch Surg 2004, 389:475-484. 10.1007/s00423-004-0472-0, 15173946.
73. Tschoeke SK, Ertel W. Immunoparalysis after multiple trauma. Injury 2007, 38:1346-1357. 10.1016/j.injury.2007.08.041, 18048039.
74. Berghe G. Neuroendocrine axis in critical illness. Curr Opin Endocrinol Diabetes 2001, 8:47-54.
75. Vanhorebeek I, Langouche L, Berghe G. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endrocrinol Metab 2006, 2:20-31.
76. Smith PD, Ochsenbauer-Jambor C, Smythies LE. Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev 2005, 206:149-159. 10.1111/j.0105-2896.2005.00288.x, 16048547.
77. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg 1993, 218:111-119. 10.1097/00000658-199308000-00001, 1242919, 8342990.
78. Suliburk J, Helmer K, Moore F, Mercer D. The gut in systemic inflammatory response syndrome and sepsis: Enzyme system/fighting multiple organ failure. Eur Surg Res 2008, 40:184-189. 10.1159/000110859, 17998777.
79. Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: What is important in human beings?. Surgery 2002, 131:241-244. 10.1067/msy.2002.116408, 11894026.
80. Fanous MYZ, Phillips AJ, Windsor JA. Mesenteric lymph: The bridge to future management of critical illness. J Pancreas 2007, 8:374-399.
81. Puxeddu I, Ribatti D, Crivallato E, Levi-Schaffer F. Mast cells and eosinophis: A novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 2005, 116:531-536. 10.1016/j.jaci.2005.06.007, 16159620.
82. Haase VH. Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 2006, 291:F271-F281. 10.1152/ajprenal.00071.2006, 16554418.
83. Lingen MW. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med 2001, 125:67-71.
84. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001, 49:507-521. 10.1016/S0008-6363(00)00281-9, 11166264.
85. Avraamides CJ, Garay-Susini B, Varner JA. Integrins in angiogenesis and lymphangiogenesis. Nature Rev Cancer 2008, 8:604-617.
86. Abedin M, Tintut Y, Demer LL. Mesenchymal stem cells and the artery wall. Circ Res 2004, 95:671-676. 10.1161/01.RES.0000143421.27684.12, 15459088.
87. Palumbo R, Bianchi ME. High mobility group box 1 protein, a cue for stem cell recruitment. Biochem Pharmacol 2004, 68:1165-1170. 10.1016/j.bcp.2004.03.048, 15313414.
88. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A. HMGB1: Endogenous danger signaling. Mol Med 2008, 14:476-484. 10.2119/2008-00034.Klune, 2323334, 18431461.
89. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, Wallace JL. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007, 21:325-332. 10.1096/fj.06-7227rev, 17267386.
90. Lawrence T, Gilroy DW. Chronic inflammation: a failure of resolution?. Int J Exp Path 2007, 88:85-94.
91. Agarwal AK, Auchus RJ. Minireview: Cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency. Endocrinology 2005, 146:2531-2538. 10.1210/en.2005-0061, 15774561.
92. Ghosh S, Hayden MS. New regulators of NF-κB in inflammation. Nature Rev 2008, 8:837-849.
93. Pasini E, Aquilani R, Dioguardi FS, D'Antona G, Gheorghiade M, Taegtmeyer H. Hypercatabolic syndrome: Molecular basis and effects of nutritional supplements with aminoacids. Am J Cardiol 2008, 101(Suppl 1):11E-15E. 10.1016/j.amjcard.2008.02.074, 18514619.
94. Hasenboehler E, Williams A, Leinhase I, Morgan SJ, Smith WR, Moore EE, Stahel PF. Metabolic changes after polytrauma: an imperative for early nutritional support. World J Emerg Surg 2006, 1:29. 10.1186/1749-7922-1-29, 1594568, 17020610.
95. Rajakariar R, Lawrence T, Bystrom J, Hilliard M, Colville-Nash P, Bellingan G, Fitzgerald D, Yaqoob MM, Gilroy DW. Novel biphasic role for lymphocytes revealed during resolving inflammation. Blood 2008, 111:4184-4192. 10.1182/blood-2007-08-108936, 2602590, 18218853.
96. Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, Spivakov M, Knight ZA, Cobb BS, Cantrell D, O'Connor E, Shokat KM, Fisher AG, Merkenschlager M. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci USA 2008, 105:7797-7802. 10.1073/pnas.0800928105, 2409380, 18509048.
97. Mäkinen T, Norrmen C, Petrova TV. Molecular mechanisms of lymphatic vascular development. Cell Mol Life Sci 2007, 64:1-15. 10.1007/s00018-007-7040-z, 17072499.
98. Ohtani O, Ohtani Y. Organization and developmental aspects of lymphatic vessels. Arch Histol Cytol 2008, 71:1-22. 10.1679/aohc.71.1, 18622090.
99. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Walter P. Small molecules, energy and biosynthesis. Molecular biology of the cell 1983, 2:43-89. Garland Publishing Inc, New York.
100. Kheirbek T, Kochanek AR, Alam HB. Hypothermia in bleeding trauma: a friend or a foe?. Scand J Trauma Resusc Emerg Med 2009, 17:65. 10.1186/1757-7241-17-65, 2806855, 20030810.
101. Brøchner AC, Toft P. Pathophysiology of the systemic inflammatory response after major accidental trauma. Scand J Trauma Resusc Emerg Med 2009, 17:43. 10.1186/1757-7241-17-43, 2757019, 19754938.
102. Acquisti C, Kieffe J, Collins S. Oxygen content of transmembrane protein over macroevolutionary time scales. Nature 2007, 445:47-52. 10.1038/nature05450, 17183269.
103. Nakamura H, Hase A. Cellular differentiation in the process of generation of the eukaryotic cell. Orig Life Evol Biosph 1991, 20:499-514.
104. Raymond J, Segre D. The effect of oxygen on biochemical networks and the evolution of complex life. Science 2006, 311:1764-1767. 10.1126/science.1118439, 16556842.
105. Baudin-Cornu P, Thomas D. Oxygen at life's boundaries. Nature 2007, 445:35-36. 10.1038/nature05521, 17183263.